Article
Pharmacogenetics of modafinil after sleep loss: catechol-O-methyltransferase genotype modulates waking functions but not recovery sleep.
Clinical pharmacology and therapeutics - 1 Mar 2009
Bodenmann S, Xu S, Luhmann U F O, Arand M, Berger W, Jung H H, Landolt H P
Abstract excerpt
Sleep loss impairs waking functions and is homeostatically compensated in recovery sleep. The mechanisms underlying the consequences of prolonged wakefulness are unknown. The stimulant modafinil may promote primarily dopaminergic neurotransmission. Catechol-O-methyltransferase (COMT) catalyzes the breakdown of cerebral dopamine. A functional Val158Met polymorphism reduces COMT activity, and Val/Val homozygous...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
